Capsules Purifithé
Capsules Purifithé, licence 80019080: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Clef des Champs Inc.
- NPN or DIN-HM
- 80019080
- Status
- Active licence
- Licence date
- 31 May 2010
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Trifolium pratense L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Frangula alnus Source : Écorce | 11.0 mg | Not calculated |
| Trifolium pratense Source : Feuille | 126.0 mg | Not calculated |
| Trifolium pratense Source : Fleur | 126.0 mg | Not calculated |
| Mahonia aquifolium Source : Racine | 16.0 mg | Not calculated |
| Juglans nigra Source : Feuille(s) | 32.0 mg | Not calculated |
Non-medicinal ingredients
cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 3.0 Capsule ; maximum: 6.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Utilisé traditionnellement en herboristerie occidentale comme altératif pour aider à soulager les affections cutanées.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un praticien de la santé si les symptômes persistent ou s'aggravent. Ne pas utiliser avec des médicaments d'ordonnance, y compris les contraceptifs oraux.
- Contre-indications
Ne pas utiliser en cas de grossesse ou d'allaitement. Ne pas utiliser en cas de troubles cardiovasculaires ou rénaux.
Source
Official Health Canada record, licence 80019080
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.